• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体介导的表皮生长因子受体抑制作用会减少小鼠的磷酸盐排泄,并导致高磷血症和轻度低镁血症。

Antibody-mediated inhibition of EGFR reduces phosphate excretion and induces hyperphosphatemia and mild hypomagnesemia in mice.

作者信息

Ortega Bernardo, Dey Jason M, Gardella Allison R, Proano Jacob, Vaneerde Deanna

机构信息

Department of Biology, The College at Brockport State University of New York, Brockport, New York

Department of Biology, The College at Brockport State University of New York, Brockport, New York.

出版信息

Physiol Rep. 2017 Mar;5(5). doi: 10.14814/phy2.13176.

DOI:10.14814/phy2.13176
PMID:28292888
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5350180/
Abstract

Monoclonal antibody therapies targeting the EGF receptor (EGFR) frequently result in hypomagnesemia in human patients. In contrast, EGFR tyrosine kinase inhibitors do not affect Mg balance in patients and only have a mild effect on Mg homeostasis in rodents at elevated doses. EGF has also been shown to affect phosphate (P) transport in rat and rabbit proximal convoluted tubules (PCT), but evidence from studies targeting EGFR and looking at P excretion in whole animals is still missing. Thus, the role of EGF in regulating reabsorption of Mg and/or P in the kidney remains controversial. Here, we inject mice with the anti-EGFR monoclonal antibody ME-1 for 2 weeks and observe a significant increase in serum P and mild hypomagnesemia, but no changes in P or Mg excretion. In contrast, a single injection of ME-1 resulted in hyperphosphatemia and a significant reduction in P excretion 2 days after treatment, while no changes in serum Mg or Mg excretion were observed. Dietary Mg deprivation is known to trigger a rapid Mg conservation response in addition to hyperphosphatemia and hyperphosphaturia. Interestingly, one dose of ME-1 did not significantly modify the response of mice to 2 days of Mg deprivation. These data show that EGFR plays a significant role in regulating P reabsorption in the kidney PCT, but suggest only a minor role in long-term regulation of Mg transport in the distal convoluted tubule.

摘要

针对表皮生长因子受体(EGFR)的单克隆抗体疗法常常会导致人类患者出现低镁血症。相比之下,EGFR酪氨酸激酶抑制剂不会影响患者的镁平衡,且只有在高剂量时才会对啮齿动物的镁稳态产生轻微影响。表皮生长因子(EGF)也已被证明会影响大鼠和兔子近端肾小管(PCT)中的磷酸盐(P)转运,但针对EGFR并观察全动物磷排泄情况的研究证据仍然缺失。因此,EGF在调节肾脏中镁和/或磷的重吸收方面的作用仍存在争议。在此,我们给小鼠注射抗EGFR单克隆抗体ME-1,持续2周,观察到血清磷显著升高和轻度低镁血症,但磷或镁的排泄没有变化。相比之下,单次注射ME-1会导致高磷血症,并在治疗后2天使磷排泄显著减少,而血清镁或镁排泄没有变化。已知饮食中缺镁除了会引发高磷血症和高磷尿症外,还会触发快速的镁保留反应。有趣的是,一剂ME-1并没有显著改变小鼠对2天缺镁的反应。这些数据表明,EGFR在调节肾脏近端肾小管的磷重吸收中起重要作用,但在远端肾小管镁转运的长期调节中仅起次要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f0/5350180/54b4f926bc92/PHY2-5-e13176-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f0/5350180/e098eff64bcd/PHY2-5-e13176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f0/5350180/a4405206ebc4/PHY2-5-e13176-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f0/5350180/304290c777c4/PHY2-5-e13176-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f0/5350180/54b4f926bc92/PHY2-5-e13176-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f0/5350180/e098eff64bcd/PHY2-5-e13176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f0/5350180/a4405206ebc4/PHY2-5-e13176-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f0/5350180/304290c777c4/PHY2-5-e13176-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f0/5350180/54b4f926bc92/PHY2-5-e13176-g004.jpg

相似文献

1
Antibody-mediated inhibition of EGFR reduces phosphate excretion and induces hyperphosphatemia and mild hypomagnesemia in mice.抗体介导的表皮生长因子受体抑制作用会减少小鼠的磷酸盐排泄,并导致高磷血症和轻度低镁血症。
Physiol Rep. 2017 Mar;5(5). doi: 10.14814/phy2.13176.
2
Hyperphosphatemia, hypocalcemia and increased serum potassium concentration as distinctive features of early hypomagnesemia in magnesium-deprived mice.高磷血症、低钙血症和血清钾浓度升高作为镁缺乏小鼠早期低镁血症的显著特征。
Magnes Res. 2015 Dec;28(4):126-35. doi: 10.1684/mrh.2015.0394.
3
Genetic causes of hypomagnesemia, a clinical overview.低镁血症的遗传病因:临床概述
Pediatr Nephrol. 2017 Jul;32(7):1123-1135. doi: 10.1007/s00467-016-3416-3. Epub 2016 May 27.
4
In brief: PPI's and hypomagnesemia.简而言之:质子泵抑制剂与低镁血症。
Med Lett Drugs Ther. 2011 Apr 4;53(1361):25.
5
Hypomagnesemia and proton-pump inhibitors.低镁血症与质子泵抑制剂。
Expert Opin Drug Saf. 2013 Sep;12(5):709-16. doi: 10.1517/14740338.2013.809062. Epub 2013 Jun 29.
6
Hypomagnesemia During Teriparatide Treatment in Osteoporosis: Incidence and Determinants.骨质疏松症患者甲状旁腺素治疗期间的低镁血症:发生率及决定因素。
J Bone Miner Res. 2018 Aug;33(8):1444-1449. doi: 10.1002/jbmr.3438. Epub 2018 May 17.
7
[Magnesium, calcium and potassium: "no one was born alone"].镁、钙与钾:“无人独自诞生”
G Ital Nefrol. 2016 Jan-Feb;33(1).
8
Identification of SLC41A3 as a novel player in magnesium homeostasis.鉴定SLC41A3为镁稳态中的新参与者。
Sci Rep. 2016 Jun 28;6:28565. doi: 10.1038/srep28565.
9
Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment.环孢素肾病大鼠模型中肾远曲小管转运蛋白 TRPM6 和 NCC 的表达及 EGF 治疗的作用。
Am J Physiol Renal Physiol. 2011 Sep;301(3):F486-93. doi: 10.1152/ajprenal.00116.2011. Epub 2011 Jun 8.
10
[Analysis of Factors Influencing the Development of Hypomagnesemia in Patients Receiving Cetuximab Therapy for Head and Neck Cancer].[接受西妥昔单抗治疗的头颈癌患者发生低镁血症的影响因素分析]
Yakugaku Zasshi. 2015;135(12):1403-7. doi: 10.1248/yakushi.15-00210.

引用本文的文献

1
Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy.2型糖尿病患者中,钠-葡萄糖协同转运蛋白2(SGLT2)抑制带来的心血管益处不会因与药物治疗相关的磷酸盐通量而受损。
World J Cardiol. 2021 Dec 26;13(12):676-694. doi: 10.4330/wjc.v13.i12.676.
2
Targeting fibroblast growth factor 23-responsive pathways uncovers controlling genes in kidney mineral metabolism.靶向成纤维细胞生长因子 23 反应途径揭示了肾脏矿物质代谢中的控制基因。
Kidney Int. 2021 Mar;99(3):598-608. doi: 10.1016/j.kint.2020.10.024. Epub 2020 Nov 4.
3
Elevated serum magnesium lowers calcification propensity in Memo1-deficient mice.

本文引用的文献

1
FGF23-Klotho signaling axis in the kidney.肾脏中的成纤维细胞生长因子23-klotho信号轴
Bone. 2017 Jul;100:62-68. doi: 10.1016/j.bone.2016.09.010. Epub 2016 Sep 10.
2
Hyperphosphatemia, hypocalcemia and increased serum potassium concentration as distinctive features of early hypomagnesemia in magnesium-deprived mice.高磷血症、低钙血症和血清钾浓度升高作为镁缺乏小鼠早期低镁血症的显著特征。
Magnes Res. 2015 Dec;28(4):126-35. doi: 10.1684/mrh.2015.0394.
3
EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade.
血清镁升高可降低 Memo1 缺陷小鼠的钙化倾向。
PLoS One. 2020 Jul 24;15(7):e0236361. doi: 10.1371/journal.pone.0236361. eCollection 2020.
表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)厄洛替尼可导致低镁血症、氧化应激和心脏功能障碍:通过阻断NK-1受体减轻上述症状。
J Cardiovasc Pharmacol. 2015 Jan;65(1):54-61. doi: 10.1097/FJC.0000000000000163.
4
The impact of dietary magnesium restriction on magnesiotropic and calciotropic genes.膳食镁限制对镁营养和钙营养基因的影响。
Nephrol Dial Transplant. 2013 Dec;28(12):2983-93. doi: 10.1093/ndt/gft358. Epub 2013 Oct 3.
5
Magnesium deficiency increases serum fibroblast growth factor-23 levels in rats.镁缺乏症会使大鼠血清成纤维细胞生长因子 23 水平升高。
Magnes Res. 2013 Jan-Feb;26(1):18-23. doi: 10.1684/mrh.2013.0331.
6
Role of the distal convoluted tubule in renal Mg2+ handling: molecular lessons from inherited hypomagnesemia.远曲小管在肾脏镁离子处理中的作用:遗传性低镁血症的分子教训。
Magnes Res. 2011 Sep;24(3):S101-8. doi: 10.1684/mrh.2011.0289.
7
Effects of the EGFR Inhibitor Erlotinib on Magnesium Handling.表皮生长因子受体抑制剂厄洛替尼对镁代谢的影响。
J Am Soc Nephrol. 2010 Aug;21(8):1309-16. doi: 10.1681/ASN.2009111153. Epub 2010 Jul 1.
8
Transcriptional activation of the human Klotho gene by epidermal growth factor in HEK293 cells; role of Egr-1.表皮生长因子在 HEK293 细胞中对人 Klotho 基因的转录激活;Egr-1 的作用。
Gene. 2010 Jan 15;450(1-2):121-7. doi: 10.1016/j.gene.2009.11.004.
9
Skeletal and hormonal effects of magnesium deficiency.镁缺乏的骨骼和激素效应。
J Am Coll Nutr. 2009 Apr;28(2):131-41. doi: 10.1080/07315724.2009.10719764.
10
Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in mice.肿瘤坏死因子-α和白细胞介素-1拮抗剂可减轻小鼠中与表皮生长因子受体抗体治疗相关的炎症性皮肤变化。
Cancer Res. 2009 Jul 15;69(14):5643-7. doi: 10.1158/0008-5472.CAN-09-0487. Epub 2009 Jul 7.